 |
|
Mixed-phenotype acute leukemia treated with decitabine
Ji-Young Lee, Sang-min Lee, Ja-Young Lee, Ki-Hyang Kim, Moon-Young Choi, Won-Sik Lee
Korean J Intern Med. 2016;31(2):406-408. Published online 2016 Feb 15 DOI: https://doi.org/10.3904/kjim.2014.353
|
|
Citations to this article as recorded by
 Venetoclax Combined with Hypomethylating Agents for Treatment-Naïve B/Myeloid Mixed Phenotype Acute Leukemia
Di Wu, Wenlan Chen, Zhichao Chen, Qiubai Li, Yusuke Shiozawa
Case Reports in Hematology.2021; 2021: 1. CrossRef Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis
Maria Maruffi, Richard Sposto, Matthew J Oberley, Lynn Kysh, Etan Orgel
Leukemia.2018; 32(7): 1515. CrossRef An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL)
Maliha Khan, Rabbia Siddiqi, Kiran Naqvi
Annals of Hematology.2018; 97(6): 945. CrossRef Decitabine
Reactions Weekly.2016; 1599(1): 87. CrossRef
|